P443: IMPACT OF PHARMACOGENETIC VARIANTS ON CYTARABINE AND ANTHRACYCLINE EFFECT ON OUTCOMES IN ADULT AML PATIENTS

• Z. Pravdic,
• M. Virijevic,
• M. Mitrovic,
• N. Pantic,
• V. Gasic,
• S. Pavlovic,
• N. Sabljic,
• D. Pavlovic,
• I. Marjanovic,
• N. Suvajdzic Vukovic

Affiliations

Z. Pravdic

1 Clinic of Hematology, UCCS

M. Virijevic

1 Clinic of Hematology, UCCS

M. Mitrovic

1 Clinic of Hematology, UCCS

N. Pantic

1 Clinic of Hematology, UCCS

V. Gasic

3 Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia

S. Pavlovic

3 Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia

N. Sabljic

1 Clinic of Hematology, UCCS

D. Pavlovic

3 Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia

I. Marjanovic

3 Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia

N. Suvajdzic Vukovic

1 Clinic of Hematology, UCCS